Pieris Pharmaceuticals to Present Preclinical Data for Inhaled IL-4Rα Antagonist AZD1402/PRS-060 at the ERS International Congress 2018

World News: . []

BOSTON Sept 14 2018 GLOBE NEWSWIRE -- a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin technology platform for cancer respiratory and other diseases, announced today that preclinical data fo...

More news and information about Pieris Pharmaceuticals, Inc.

Published By:

Globe Newswire: 13:00 GMT Friday 14th September 2018

Published: .

Search for other references to "pieris" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us